IMAAVY® is a targeted approach for autoantibody diseaseIMAAVY® is a targeted approach for autoantibody disease

Discover IMAAVY® (nipocalimab-aahu)
for the following conditions

Generalized myasthenia gravis (gMG)

For patients 12 years and older who are anti-AChR or anti-MuSK antibody-positive

Warm autoimmune hemolytic anemia (wAIHA)

For patients 12 years and older currently or previously treated with corticosteroids

AChR=acetylcholine receptor; MuSK=muscle-specific tyrosine kinase.